Bellicum Pharmaceuticals, Inc. (BLCM)
BLCM has a market cap or net worth of $2.43 million. The enterprise value is -$3.48 million.
The last earnings date was Tuesday, August 29, 2023, after market close.
|Earnings Date||Aug 29, 2023|
BLCM has 9.72 million shares outstanding. The number of shares has increased by 0.24% in one year.
|Shares Change (YoY)||+0.24%|
|Shares Change (QoQ)||+0.23%|
|Owned by Insiders (%)||1.23%|
|Owned by Institutions (%)||25.05%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 3.04
|Debt / Equity||n/a|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
|Return on Equity (ROE)||n/a|
|Return on Assets (ROA)||-318.07%|
|Return on Capital (ROIC)||n/a|
|Revenue Per Employee||$116,000|
|Profits Per Employee||-$1.68M|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -81.73% in the last 52 weeks. The beta is 1.36, so BLCM's price volatility has been higher than the market average.
|52-Week Price Change||-81.73%|
|50-Day Moving Average||0.23|
|200-Day Moving Average||0.44|
|Relative Strength Index (RSI)||56.36|
|Average Volume (30 Days)||17,065|
Short Selling Information
The latest short interest is 1.44 million, so 14.81% of the outstanding shares have been sold short.
|Short Previous Month||527,201|
|Short % of Shares Out||14.81%|
|Short % of Float||22.92%|
|Short Ratio (days to cover)||0.17|
In the last 12 months, BLCM had revenue of $1.51 million and -$21.80 million in losses. Loss per share was -$1.58.
|Loss Per Share||-$1.58|
The company has $5.91 million in cash and no debt, giving a net cash position of $5.91 million or $0.61 per share.
|Cash & Cash Equivalents||5.91M|
|Net Cash Per Share||$0.61|
|Equity / Book Value||-27.01M|
|Book Value Per Share||-2.78|
In the last 12 months, operating cash flow was -$22.85 million and capital expenditures -$11,000, giving a free cash flow of -$22.86 million.
|Operating Cash Flow||-22.85M|
|Free Cash Flow||-22.86M|
|FCF Per Share||-$0.74|
Gross margin is 100.00%, with operating and profit margins of -1,528.71% and -1,445.42%.
Dividends & Yields
BLCM does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
|Price Target Difference||n/a|
|Revenue Growth Forecast (5Y)||n/a|
|EPS Growth Forecast (5Y)||n/a|
The last stock split was on February 6, 2020. It was a reverse split with a ratio of 1:10.
|Last Split Date||Feb 6, 2020|
BLCM has an Altman Z-Score of -131.99 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.